The Vita Coco Company, Inc. (NASDAQ:COCO) (“Vita Coco” or “the
Company”), a leading high-growth platform of better-for-you
beverage brands, today announced financial results for the third
quarter ended September 30, 2024.
Third Quarter and Year-To-Date 2024
Highlights Compared to Prior Year Period
- Net sales declined 4% in the third
quarter to $133 million resulting in year-to-date being flat
at $389 million.
- Vita Coco Coconut
Water net sales growth of 8% in the third quarter and 5%
year-to-date.
- Gross profit was
$52 million in the third quarter, a decrease of
$5 million and $157 million year-to-date, an increase of
$17 million.
- Gross margin was
39% of net sales in the third quarter compared to 41% of net sales,
and 41% of net sales year-to-date as compared to 36% of net
sales.
- Net income was
$19 million in the third quarter compared to net income of
$15 million, and year-to-date was $53 million compared to
$40 million.
- Net income per
diluted share was $0.32 in the third quarter compared to $0.26, and
was $0.89 per diluted share year-to-date compared to $0.68.
- Non-GAAP Adjusted EBITDA1 for the third
quarter was $23 million compared to $27 million and
year-to-date was $76 million, compared to
$60 million.
Michael Kirban, the Company's Co-Founder and Executive Chairman,
stated, "I am very proud of our team and our performance during the
third quarter. The coconut water category remains one of the
fastest growing categories in the beverage aisle, and we believe
this growth is being fueled by our focus as the category leader in
driving increased household adoption and new consumption occasions.
Our reduced inventory availability during most of the quarter
limited our ability to meet consumer demand. With an improving
inventory situation, I expect accelerated growth for the balance of
the year. Based on our expectation for continued strong category
growth in 2025, I could not be more excited for what is to
come."
Martin Roper, the Company’s Chief Executive Officer, said, “Our
sales performance in the quarter was affected by our inventory
flow, which was lower than we had planned due to the difficulty in
obtaining ocean freight containers that started in the second
quarter. We are pleased that we have weathered these shortages and,
in late September, saw our product flow and availability in market
improving. Based on continued strong category growth and improved
inventory levels, we are raising our full year guidance for net
sales and adjusted EBITDA."
Third Quarter 2024 Consolidated Results
Net sales decreased $5 million, or 4%, to $133 million
for the third quarter ended September 30, 2024, compared to
$138 million in the prior year period. The decrease in net
sales was driven by declines in private label case equivalent
("CE") volume which more than offset the Vita Coco Coconut Water CE
volume growth. The decline in private label was due to the
reduction in private label oil sales, coupled with lower private
label water volumes due primarily to supply constraints.
Gross profit was $52 million for the third quarter of 2024,
compared to $56 million in the prior year period. Gross margin
of 39% in the third quarter of 2024 decreased from 41% in the prior
year period. Gross profit decrease was driven by lower overall
volumes and increased transportation costs, which were partially
offset by increased Vita Coco Coconut Water net pricing and
price/mix effects in private label.
Selling, general and administrative ("SG&A") expenses in the
third quarter of 2024 were $31 million, compared to
$33 million in the prior year period. The decrease was largely
due to the timing of marketing investments, which was partially
offset by higher year on year personnel expenses.
Net income was $19 million, or $0.32 per diluted share, for
the third quarter of 2024, compared to net income of
$15 million, or $0.26 per diluted share, in the prior year
period. Net income benefited from a gain on mark to market
adjustment on derivative instruments, lower SG&A expenses and
higher interest income driven by higher cash investments compared
to the prior year period, partly offset by lower year-on-year gross
profit.
Non-GAAP Adjusted EBITDA1 for the third quarter of 2024 was
$23 million, compared to $27 million in the prior year
period. The decrease in Adjusted EBITDA1 was primarily driven by
lower gross profit resulting primarily from reduced volume and
higher transportation costs, which were partially offset by higher
Vita Coco Coconut Water net pricing, price/mix effects in private
label, and lower SG&A.
Balance Sheet
As of September 30, 2024, the Company had cash and cash
equivalents of $157 million, compared to $133 million as
of December 31, 2023. There was no debt as of
September 30, 2024 and December 31, 2023. Inventories as
of September 30, 2024 totaled $65 million. On
September 30, 2024, there were 56,731,839 shares of common
stock outstanding.
On October 30, 2023, the Company's Board of Directors approved a
share repurchase program authorizing the Company to repurchase up
to $40 million of the Company's common stock. As of
September 30, 2024, and to date, the Company has repurchased a
total of 534,246 shares for an aggregate value of $12.8 million at
an average share price of $23.97 with 112,702 shares repurchased
during the most recent quarter.
Fiscal Year 2024 Full Year Outlook
The Company is raising its full year guidance for net sales and
adjusted EBITDA:
- Expect 2024 net sales to be
between $505 million and $515 million, with projected Vita Coco
Coconut Water and private label coconut water volume growth, being
offset by expected decreases in private label coconut oil business
and price/mix effects.
- Full year gross margin expected to
be between 37% and 39%, with recent increases on certain ocean
freight routes expected to adversely affect gross margins in the
fourth quarter.
- SG&A expenses
expected to be flat to slightly down versus 2023.
- Forecasting adjusted EBITDA in the
range of $80 million to $84 million.2
Uncertainty and instability of the current operating
environment, global economies, and geopolitical landscape could
affect this outlook and our future results.
Footnotes:
(1) Adjusted EBITDA represents earnings before interest, taxes,
depreciation, and amortization as adjusted for certain items as set
forth in the reconciliation table of U.S. GAAP to
non-GAAP information and is a measure calculated and presented on
the basis of methodologies other than in accordance with GAAP.
Please refer to the Non-GAAP Financial Measures herein for further
discussion and reconciliation of this measure to GAAP measures.
(2) GAAP Net Income 2024 outlook is not provided due to the
inherent difficulty in quantifying certain amounts due to a variety
of factors including the unpredictability in the movement in
foreign currency rates, as well as future charges or reversals
outside of the normal course of business.
Conference Call and Webcast DetailsThe Vita
Coco Company will host a conference call and webcast at 8:30 a.m.
ET today to discuss these results. To participate in the live
earnings call and question and answer session, please register
at https://register.vevent.com/register/BIeece4f80fe3a40e8a082f9df6582c25c and
dial-in information will be provided directly to you. A slide
presentation to support the webcast, and the live audio webcast
will be accessible in the “Events” section of the Company’s
Investor Relations website at
https://investors.thevitacococompany.com. An archived replay of the
webcast will be available shortly after the live event has
concluded.
About The Vita Coco Company
The Vita Coco Company is a family of brands on a mission to
reimagine what’s possible when brands deliver healthy, nutritious,
and great tasting products that are better for consumers and better
for the world. This includes its flagship coconut water brand Vita
Coco, sustainably packaged water Ever & Ever, and
protein-infused water PWR LIFT. The Company was co-founded in 2004
by Michael Kirban and Ira Liran and is a public benefit corporation
and Certified B Corporation. Vita Coco, the principal brand within
the Company’s portfolio, is the leading coconut water brand in the
U.S. With electrolytes, nutrients, and vitamins, coconut water has
become a top beverage choice among consumers after a workout, in
smoothies, as a cocktail mixer, after a night out, and more.
Contacts
Investor Relations: ICR,
Inc.investors@thevitacococompany.com
Non-GAAP Financial Measures
In addition to disclosing results determined in accordance
with U.S. GAAP, the Company also discloses certain
non-GAAP results of operations, including, but not limited to,
Adjusted EBITDA, that include certain adjustments or exclude
certain charges and gains that are described in the reconciliation
table of U.S. GAAP to non-GAAP information provided at
the end of this release. These non-GAAP measures are a key metric
used by management and our board of directors to assess our
financial performance across reporting periods on a consistent
basis by excluding items that we do not believe are indicative of
our core operating performance and because we believe it is useful
for investors to see the measures that management uses to evaluate
the Company. In addition, we believe the presentation of these
measures is useful to investors for period-to-period comparisons of
results as the items described below in the reconciliation tables
do not reflect ongoing operating performance.
These measures are not in accordance with, or an alternative
to, U.S. GAAP, and may be different from non-GAAP
measures used by other companies. In addition, other companies,
including companies in our industry, may calculate such measures
differently, which reduces its usefulness as a comparative measure.
Investors should not rely on any single financial measure when
evaluating our business. This information should be considered as
supplemental in nature and is not meant as a substitute for our
operating results in accordance with U.S. GAAP. We
recommend investors review the U.S. GAAP financial
measures included in this earnings release. When viewed in
conjunction with our U.S. GAAP results and the
accompanying reconciliations, we believe these non-GAAP measures
provide greater transparency and a more complete understanding of
factors affecting our business than U.S. GAAP measures
alone.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. All statements contained in this press release that do not
relate to matters of historical fact should be considered
forward-looking statements, including but not limited to,
statements regarding our future financial and operating
performance, including our GAAP and non-GAAP guidance, our
strategy, projected costs, prospects, expectations, plans,
objectives of management, supply chain predictions, customer and
supplier relationships, and expected net sales and category share
growth.
The forward-looking statements in this release are only
predictions. We have based these forward-looking statements largely
on our current expectations and projections about future events and
financial trends that we believe may affect our business, financial
condition and results of operations. Forward-looking statements
involve known and unknown risks, uncertainties and other important
factors that may cause our actual results, performance or
achievements to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements. Forward-looking statements involve a
number of risks, uncertainties or other factors beyond the
Company’s control. These factors include, but are not limited to,
those discussed under the caption “Risk Factors” in our Annual
Reports on Form 10-K, Quarterly Reports on Form 10-Q and our other
filings with the U.S. Securities and Exchange Commission ("SEC") as
such factors may be updated from time to time and which are
accessible on the SEC’s website at www.sec.gov and the Investor
Relations page of our website at
https://investors.thevitacococompany.com. Any forward-looking
statements contained in this press release speak only as of the
date hereof and accordingly undue reliance should not be placed on
such statements. We disclaim any obligation or undertaking to
update or revise any forward-looking statements contained in this
press release, whether as a result of new information, future
events or otherwise, other than to the extent required by
applicable law.
Website Disclosure
We intend to use our websites, vitacoco.com and
investors.thevitacococompany.com, as a means for disclosing
material non-public information and for complying with the SEC's
Regulation FD and other disclosure obligations.
|
THE VITA COCO COMPANY, INC.CONSOLIDATED
BALANCE SHEETS(Amounts in thousands, except share
data) |
|
|
|
September 30,2024 |
|
December 31,2023 |
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ |
156,706 |
|
|
$ |
132,537 |
|
Accounts receivable, net of allowance of $2,257 at
September 30, 2024, and $2,486 at December 31, 2023 |
|
78,600 |
|
|
|
50,086 |
|
Inventory |
|
64,905 |
|
|
|
50,757 |
|
Supplier advances, current |
|
1,265 |
|
|
|
1,521 |
|
Derivative assets |
|
1,299 |
|
|
|
3,876 |
|
Prepaid expenses and other current assets |
|
27,986 |
|
|
|
24,160 |
|
Total current assets |
|
330,761 |
|
|
|
262,937 |
|
Property and equipment,
net |
|
2,440 |
|
|
|
2,136 |
|
Goodwill |
|
7,791 |
|
|
|
7,791 |
|
Supplier advances,
long-term |
|
2,732 |
|
|
|
2,820 |
|
Deferred tax assets, net |
|
6,756 |
|
|
|
6,749 |
|
Right-of-use assets, net |
|
648 |
|
|
|
1,406 |
|
Other assets |
|
2,019 |
|
|
|
1,843 |
|
Total assets |
$ |
353,147 |
|
|
$ |
285,682 |
|
Liabilities and
Stockholders’ Equity |
|
|
|
Current liabilities: |
|
|
|
Accounts payable |
$ |
31,253 |
|
|
$ |
21,826 |
|
Accrued expenses and other current liabilities |
|
64,908 |
|
|
|
59,533 |
|
Notes payable, current |
|
10 |
|
|
|
13 |
|
Derivative liabilities |
|
4,533 |
|
|
|
1,213 |
|
Total current liabilities |
|
100,704 |
|
|
|
82,585 |
|
Notes payable, long-term |
|
5 |
|
|
|
13 |
|
Other long-term
liabilities |
|
318 |
|
|
|
647 |
|
Total liabilities |
$ |
101,027 |
|
|
$ |
83,245 |
|
Stockholders’ equity: |
|
|
|
Common stock, $0.01 par value;
500,000,000 shares authorized; 63,472,285 and 63,135,453 shares
issued at September 30, 2024 and December 31, 2023,
respectively 56,731,839 and 56,899,253 shares outstanding at
September 30, 2024 and December 31, 2023,
respectively |
|
635 |
|
|
|
631 |
|
Additional paid-in
capital |
|
169,736 |
|
|
|
161,414 |
|
Retained earnings |
|
153,324 |
|
|
|
100,742 |
|
Accumulated other
comprehensive loss |
|
156 |
|
|
|
(649 |
) |
Treasury stock, 6,740,446
shares at cost as of September 30, 2024, and 6,236,200 shares
at cost as of December 31, 2023. |
|
(71,731 |
) |
|
|
(59,701 |
) |
Total stockholders’ equity |
|
252,120 |
|
|
|
202,437 |
|
Total liabilities and stockholders’ equity |
$ |
353,147 |
|
|
$ |
285,682 |
|
|
|
|
|
|
|
|
|
|
THE VITA COCO COMPANY, INC.CONSOLIDATED
STATEMENTS OF OPERATIONS(Amounts in thousands,
except for share and per share data) |
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Net sales |
$ |
132,906 |
|
|
$ |
138,064 |
|
|
$ |
388,720 |
|
|
$ |
387,468 |
|
Cost of goods sold |
|
81,344 |
|
|
|
81,893 |
|
|
|
231,244 |
|
|
|
246,542 |
|
Gross profit |
|
51,562 |
|
|
|
56,171 |
|
|
|
157,476 |
|
|
|
140,926 |
|
Operating expenses |
|
|
|
|
|
|
|
Selling, general and administrative |
|
30,967 |
|
|
|
32,649 |
|
|
|
87,941 |
|
|
|
89,855 |
|
Income (Loss) from
operations |
|
20,595 |
|
|
|
23,522 |
|
|
|
69,535 |
|
|
|
51,071 |
|
Other income (expense) |
|
|
|
|
|
|
|
Unrealized gain/(loss) on derivative instruments |
|
2,592 |
|
|
|
(3,959 |
) |
|
|
(5,896 |
) |
|
|
(1,758 |
) |
Foreign currency gain/(loss) |
|
550 |
|
|
|
(1,211 |
) |
|
|
472 |
|
|
|
(430 |
) |
Interest income |
|
1,876 |
|
|
|
824 |
|
|
|
5,026 |
|
|
|
1,105 |
|
Interest expense |
|
— |
|
|
|
(1 |
) |
|
|
— |
|
|
|
(31 |
) |
Total other income (expense) |
|
5,018 |
|
|
|
(4,347 |
) |
|
|
(398 |
) |
|
|
(1,114 |
) |
Income before income
taxes |
|
25,613 |
|
|
|
19,175 |
|
|
|
69,137 |
|
|
|
49,957 |
|
Income tax expense |
|
(6,362 |
) |
|
|
(4,011 |
) |
|
|
(16,555 |
) |
|
|
(10,101 |
) |
Net income |
$ |
19,251 |
|
|
$ |
15,164 |
|
|
$ |
52,582 |
|
|
$ |
39,856 |
|
Net income per common
share |
|
|
|
|
|
|
|
Basic |
$ |
0.34 |
|
|
$ |
0.27 |
|
|
$ |
0.93 |
|
|
$ |
0.71 |
|
Diluted |
$ |
0.32 |
|
|
$ |
0.26 |
|
|
$ |
0.89 |
|
|
$ |
0.68 |
|
Weighted-average number of
common shares outstanding |
|
|
|
|
|
|
|
Basic |
|
56,769,410 |
|
|
|
56,493,757 |
|
|
|
56,688,362 |
|
|
|
56,290,195 |
|
Diluted |
|
59,314,805 |
|
|
|
59,271,757 |
|
|
|
59,099,179 |
|
|
|
58,494,045 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
THE VITA COCO COMPANY, INC.CONSOLIDATED
STATEMENTS OF CASH FLOWS(Amounts in
thousands) |
|
|
|
Nine Months Ended September 30, |
|
|
2024 |
|
|
|
2023 |
|
Cash flows from
operating activities: |
|
|
|
Net income |
$ |
52,582 |
|
|
$ |
39,856 |
|
Adjustments required to reconcile net income to cash flows from
operating activities: |
|
|
|
Depreciation and amortization |
|
540 |
|
|
|
503 |
|
(Gain)/loss on disposal of equipment |
|
13 |
|
|
|
19 |
|
Bad debt expense |
|
(665 |
) |
|
|
255 |
|
Unrealized (gain)/loss on derivative instruments |
|
5,896 |
|
|
|
1,758 |
|
Stock-based compensation |
|
6,649 |
|
|
|
7,126 |
|
Impairment loss on assets held for sale |
|
— |
|
|
|
363 |
|
Noncash lease expense |
|
764 |
|
|
|
966 |
|
Changes in operating assets and liabilities: |
|
|
|
Accounts receivable |
|
(26,910 |
) |
|
|
(37,234 |
) |
Inventory |
|
(13,974 |
) |
|
|
33,815 |
|
Prepaid expenses, net supplier advances, and other assets |
|
(2,585 |
) |
|
|
5,215 |
|
Accounts payable, accrued expenses, and other liabilities |
|
13,667 |
|
|
|
17,361 |
|
Net cash provided by (used in) operating activities |
|
35,977 |
|
|
|
70,003 |
|
Cash flows from
investing activities: |
|
|
|
Cash paid for property and equipment |
|
(849 |
) |
|
|
(533 |
) |
Proceeds from sale of property and equipment |
|
— |
|
|
|
5 |
|
Net cash used in investing activities |
|
(849 |
) |
|
|
(528 |
) |
Cash flows from
financing activities: |
|
|
|
Proceeds from exercise of stock awards |
|
1,676 |
|
|
|
5,915 |
|
Cash paid on notes payable |
|
(10 |
) |
|
|
(18 |
) |
Cash paid to acquire treasury stock |
|
(12,030 |
) |
|
|
— |
|
Net cash provided by (used in) financing activities |
|
(10,364 |
) |
|
|
5,897 |
|
Effects of exchange rate changes on cash and cash equivalents |
|
333 |
|
|
|
212 |
|
Net increase/(decrease) in cash and cash equivalents |
|
25,097 |
|
|
|
75,584 |
|
Cash, cash equivalents and
restricted cash at beginning of the period (1) |
|
132,867 |
|
|
|
19,629 |
|
Cash, cash equivalents and
restricted cash at end of the period (1) |
|
157,964 |
|
|
|
95,213 |
|
|
|
|
|
|
|
|
|
1 Includes $1,258 and $328 of restricted cash as of
September 30, 2024 and 2023, respectively, that were included
in other current assets.
RECONCILIATION FROM GAAP NET INCOME
TO NON-GAAP ADJUSTED EBITDA
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(in thousands) |
|
(in thousands) |
Net income |
|
19,251 |
|
|
|
15,164 |
|
|
$ |
52,582 |
|
|
$ |
39,856 |
|
Depreciation and
amortization |
|
196 |
|
|
|
163 |
|
|
|
540 |
|
|
|
503 |
|
Interest income |
|
(1,876 |
) |
|
|
(824 |
) |
|
|
(5,026 |
) |
|
|
(1,105 |
) |
Interest expense |
|
— |
|
|
|
1 |
|
|
|
— |
|
|
|
31 |
|
Income tax expense |
|
6,362 |
|
|
|
4,011 |
|
|
|
16,555 |
|
|
|
10,101 |
|
EBITDA |
|
23,933 |
|
|
|
18,515 |
|
|
|
64,651 |
|
|
|
49,386 |
|
Stock-based compensation
(a) |
|
2,141 |
|
|
|
2,862 |
|
|
|
6,649 |
|
|
|
7,126 |
|
Unrealized (gain)/loss on
derivative instruments (b) |
|
(2,592 |
) |
|
|
3,959 |
|
|
|
5,896 |
|
|
|
1,758 |
|
Foreign currency (gain)/loss
(b) |
|
(550 |
) |
|
|
1,211 |
|
|
|
(472 |
) |
|
|
430 |
|
Secondary Offering Costs
(c) |
|
— |
|
|
|
— |
|
|
|
(324 |
) |
|
|
856 |
|
Other adjustments (d) |
|
— |
|
|
|
329 |
|
|
|
— |
|
|
|
329 |
|
Adjusted EBITDA |
$ |
22,932 |
|
|
$ |
26,876 |
|
|
$ |
76,400 |
|
|
$ |
59,885 |
|
|
(a) Non-cash charges related to stock-based compensation, which
vary from period to period depending on volume and vesting timing
of awards and forfeitures. We adjusted for these charges to
facilitate comparison from period to period.(b) Unrealized gains or
losses on derivative instruments and foreign currency gains or
losses are not considered in our evaluation of our ongoing
performance.(c) Reflects other non-recurring expense/(income)
related to costs associated with two secondary offerings in which
Verlinvest Beverages SA sold shares of the Company in an
underwritten public offering that closed on May 26, 2023 and a
block trade that was executed on November 9, 2023. The amounts for
the three and nine months ended September 30, 2023 relate to costs
for the May 26, 2023 offering. The amounts for the three and nine
months ended September 30, 2024 relate to an expense waiver of
certain costs incurred during the November 9, 2023 block trade. The
Company did not receive any proceeds from the sale of the
shares.(d) Reflects other charges primarily related to the
impairment loss related to assets held for sale in 2023 and other
non-recurring expenses.
SUPPLEMENTAL INFORMATION
|
NET SALES |
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
(in thousands) |
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Americas
segment |
|
|
|
|
|
|
|
Vita Coco Coconut Water |
$ |
94,013 |
|
|
$ |
89,683 |
|
|
$ |
262,029 |
|
|
$ |
253,825 |
|
Private Label |
|
16,489 |
|
|
|
28,257 |
|
|
|
63,897 |
|
|
|
77,366 |
|
Other |
|
1,744 |
|
|
|
2,706 |
|
|
|
6,913 |
|
|
|
7,490 |
|
Subtotal |
$112,246 |
|
|
$120,646 |
|
|
$332,839 |
|
|
$338,681 |
|
International
segment |
|
|
|
|
|
|
|
Vita Coco Coconut Water |
$ |
14,883 |
|
|
$ |
11,350 |
|
|
$ |
38,500 |
|
|
$ |
33,628 |
|
Private Label |
|
4,800 |
|
|
|
5,421 |
|
|
|
14,768 |
|
|
|
13,140 |
|
Other |
|
977 |
|
|
|
647 |
|
|
|
2,613 |
|
|
|
2,019 |
|
Subtotal |
$ |
20,660 |
|
|
$ |
17,418 |
|
|
$ |
55,881 |
|
|
$ |
48,787 |
|
Total net sales |
$ |
132,906 |
|
|
$ |
138,064 |
|
|
$ |
388,720 |
|
|
$ |
387,468 |
|
|
|
|
|
COST OF GOODS SOLD & GROSS PROFIT |
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
(in thousands) |
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Cost of goods
sold |
|
|
|
|
|
|
|
Americas segment |
$ |
68,681 |
|
|
$ |
70,437 |
|
|
$ |
196,195 |
|
|
$ |
214,214 |
|
International segment |
|
12,663 |
|
|
|
11,456 |
|
|
|
35,049 |
|
|
|
32,328 |
|
Total cost of goods sold |
$ |
81,344 |
|
|
$ |
81,893 |
|
|
$ |
231,244 |
|
|
$ |
246,542 |
|
Gross
profit |
|
|
|
|
|
|
|
Americas segment |
$ |
43,563 |
|
|
$ |
50,208 |
|
|
$ |
136,643 |
|
|
$ |
124,466 |
|
International segment |
|
7,999 |
|
|
|
5,963 |
|
|
|
20,833 |
|
|
|
16,460 |
|
Total gross profit |
$ |
51,562 |
|
|
$ |
56,171 |
|
|
$ |
157,476 |
|
|
$ |
140,926 |
|
Gross
margin |
|
|
|
|
|
|
|
Americas segment |
|
38.8 |
% |
|
|
41.6 |
% |
|
|
41.1 |
% |
|
|
36.8 |
% |
International segment |
|
38.7 |
% |
|
|
34.2 |
% |
|
|
37.3 |
% |
|
|
33.7 |
% |
Consolidated |
|
38.8 |
% |
|
|
40.7 |
% |
|
|
40.5 |
% |
|
|
36.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VOLUME (CE) |
|
Percentage Change - Three Months Ended September 30, 2024
vs. 2023 |
|
Americas |
|
|
International |
|
|
Total |
|
Vita Coco Coconut Water |
2.9 |
|
% |
|
27.2 |
|
% |
|
6.3 |
|
% |
Private Label |
(32.1 |
) |
% |
|
(4.7 |
) |
% |
|
(27.0 |
) |
% |
Other |
(38.9 |
) |
% |
|
134.7 |
|
% |
|
(32.3 |
) |
% |
Total volume (CE) |
(6.8 |
) |
% |
|
17.4 |
|
% |
|
(3.1 |
) |
% |
|
|
|
|
|
|
|
|
|
|
Percentage Change - Nine Months Ended September 30, 2024
vs. 2023 |
|
Americas |
|
|
International |
|
|
Total |
|
Vita Coco Coconut Water |
0.6 |
|
% |
|
8.0 |
|
% |
|
1.7 |
|
% |
Private Label |
(7.6 |
) |
% |
|
18.5 |
|
% |
|
(3.1 |
) |
% |
Other |
(18.8 |
) |
% |
|
23.6 |
|
% |
|
(16.2 |
) |
% |
Total volume (CE) |
(1.7 |
) |
% |
|
10.9 |
|
% |
|
0.2 |
|
% |
|
|
|
Note: A CE is a standard volume measure used by management which
is defined as a case of 12 bottles of 330ml liquid beverages or the
same liter volume of oil.
*International Other excludes minor volume that is treated as
zero CE
Grafico Azioni Vita Coco (NASDAQ:COCO)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Vita Coco (NASDAQ:COCO)
Storico
Da Gen 2024 a Gen 2025